The Defense Department last month launched a new study to assess emerging biotechnologies and national security, a project required by law that was supposed to begin a year ago and which will likely be further delayed due to a department-wide review of all federal advisory committee activity mandated by the defense secretary. On Feb. 4, the Defense Science Board posted a memo directing a study on emerging biotechnologies pertinent to national security . The directive was issued on Jan. 21...
